company background image
8HH logo

Avanos Medical DB:8HH Stock Report

Last Price

€19.40

Market Cap

€841.0m

7D

10.2%

1Y

0%

Updated

12 Nov, 2024

Data

Company Financials +

8HH Stock Overview

A medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

8HH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Avanos Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Avanos Medical
Historical stock prices
Current Share PriceUS$19.40
52 Week HighUS$22.00
52 Week LowUS$16.20
Beta0.92
11 Month Change-3.96%
3 Month Change-4.90%
1 Year Change0%
33 Year Change-33.10%
5 Year Change-34.01%
Change since IPO-34.89%

Recent News & Updates

Recent updates

Shareholder Returns

8HHDE Medical EquipmentDE Market
7D10.2%7.8%1.1%
1Y0%4.6%13.5%

Return vs Industry: 8HH underperformed the German Medical Equipment industry which returned 4.6% over the past year.

Return vs Market: 8HH underperformed the German Market which returned 13.5% over the past year.

Price Volatility

Is 8HH's price volatile compared to industry and market?
8HH volatility
8HH Average Weekly Movement6.4%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8HH has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 8HH's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20143,771Michael Greineravanos.com

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems.

Avanos Medical, Inc. Fundamentals Summary

How do Avanos Medical's earnings and revenue compare to its market cap?
8HH fundamental statistics
Market cap€841.03m
Earnings (TTM)€20.44m
Revenue (TTM)€641.84m

39.6x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8HH income statement (TTM)
RevenueUS$681.50m
Cost of RevenueUS$303.20m
Gross ProfitUS$378.30m
Other ExpensesUS$356.60m
EarningsUS$21.70m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.50
Gross Margin55.51%
Net Profit Margin3.18%
Debt/Equity Ratio13.2%

How did 8HH perform over the long term?

See historical performance and comparison